Cancer News and Research

Latest Cancer News and Research

Cancer Research UK launches a new Cancer Centre at Cardiff

Cardiff today (Thursday) joins a unique chain of Cancer Research UK Centres that are being launched across the UK.

10 Sep 2009

Complete Genomics sequences and delivers 14 human genomes

Complete Genomics Inc., a third-generation human genome sequencing company, announced today that it has sequenced, analyzed and delivered 14 human genomes to customers since March 2009.

10 Sep 2009

SRA to provide scientific peer review services to Cancer Prevention and Research Institute of Texas

SRA International, Inc. (NYSE: SRX), a leading provider of technology and strategic consulting services and solutions to government organizations and commercial clients, today announced it has won a contract from the Cancer Prevention and Research Institute of Texas (CPRIT) to provide scientific peer review services. The contract is worth $16.2 million over five years, if all options are exercised. Work on the contract began July 1, 2009.

10 Sep 2009

Business operations to be hit in the event of H1N1 outbreak

In a national survey of businesses that looks at their preparations for a possible widespread H1N1 outbreak, Harvard School of Public Health (HSPH) researchers found that only one-third believe they could sustain their business without severe operational problems if half their workforce were absent for two weeks due to H1N1 (also known as "swine flu").

10 Sep 2009

Lack of awareness in aged men reagarding prostate cancer treatment options

Prostate cancer remains one of the most commonly diagnosed cancers in the United States. In fact, one in six men will develop prostate cancer. It is also the second-leading cause of cancer death in the United States. But a recent survey suggests that many men at risk for the cancer still aren't aware of all available treatment options.

10 Sep 2009

Nanobio hybrids for brain cancer therapy

In an advance toward better treatments for the most serious form of brain cancer, scientists in Illinois are reporting development of the first nanoparticles that seek out and destroy brain cancer cells without damaging nearby healthy cells. The study is scheduled for the Sept. 9 issue of ACS' Nano Letters, a monthly journal.

10 Sep 2009

Therapeutic principles of monoclonal antibodies

Professor Joachim R. Kalden, Member of the Department for Molecular Immunology, Nikolaus-Fiebiger-Zentrum, University Medical School Erlangen-Nuremberg, presents therapeutic principles based on monoclonal antibodies.

10 Sep 2009

New type of stem cell in the prostate may be a source for prostate cancer, say researchers

A new type of stem cell discovered in the prostate of adult mice can be a source of prostate cancer, according to a new study by researchers at the Herbert Irving Comprehensive Cancer Center at Columbia University Medical Center and NewYork-Presbyterian Hospital.

10 Sep 2009

New Influenza A/H1N1 detection kit launched

QIAGEN, today announced both the launch of a new Influenza A/H1N1 test and several updates to its activities in providing solutions for the global surveillance of the swine flu pandemic. QIAGEN’s new kit enables both the highly sensitive and specific detection of the novel Influenza A/H1N1, the virus that causes “swine flu”, as well as of all other known Influenza A and B virus strains.

10 Sep 2009

Vespa USA supports breast cancer awareness programs

The next time you see a distinctively pink Vespa zooming by, it might just be one of the Vespa LX 50 scooters that over a dozen non-profit agencies devoted to battling breast cancer are adding to their autumn Breast Cancer Awareness initiatives.

10 Sep 2009

Roche Group and ImmunoCellular Therapeutics sign research agreement regarding ICT-69 antibody

ImmunoCellular Therapeutics, Ltd. (OTCBB: IMUC), a clinical-stage biotechnology company that is developing immune based therapies for the treatment of brain and other cancers, announced today that it has entered into a research and license option agreement regarding its ICT-69 antibody with Roche Group (SWX: ROG.VX; RO.S, OTCQX: RHHBY), one of the world’s leading research-focused healthcare groups in the fields of pharmaceuticals and diagnostics.

10 Sep 2009

Lead exposure may result in cardiovascular mortality

Growing evidence shows that exposure to lead in the environment is associated with cardiovascular disease, including increased risk of hypertension. However, those studies have looked at lead concentrations in blood, not bone lead, a better indicator of cumulative lead exposure over time.

10 Sep 2009

Oral and throat cancers linked to human papilloma virus

Infection by the human papilloma virus (HPV), the most common sexually transmitted disease, has been linked to more than one third of all oral and throat cancers according to Dr. Solomon Hamburg, president of the prestigious Tower Cancer Research Foundation.

10 Sep 2009

GlaxoSmithKline's CERVARIX receives favorable recommendation from FDA Advisory Committee

GlaxoSmithKline (NYSE: GSK) announced today that the U.S. Food and Drug Administration's (FDA) Vaccines and Related Biological Products Advisory Committee (VRBPAC) voted that clinical data support both the efficacy and safety of CERVARIX((R)), the company's candidate cervical cancer vaccine (12-1 and 11-1, respectively).

10 Sep 2009

Nasdaq Stock Market issues delisting notice to Metabasis Therapeutics

Metabasis Therapeutics, Inc. (Nasdaq:MBRX) announced today that on September 4, 2009 it received a letter from the Listing Qualifications Staff of The Nasdaq Stock Market (the “Staff”) notifying the Company that it did not comply with the minimum $2,500,000 stockholders' equity requirement for continued listing, set forth in Listing Rule 5550(b), prior to the expiration of the extension for such compliance granted by the Staff on June 25, 2009, and that as a result, unless the Company requests an appeal of the Staff’s delisting determination, trading of the Company’s common stock on the Nasdaq Capital Market will be suspended at the opening of business on September 15, 2009.

10 Sep 2009

Society of Interventional Radiology's resources emphasize on PAD

The Society of Interventional Radiology offers numerous resources just in time for September's national peripheral arterial disease (or PAD) awareness month. As recent medical studies continue to highlight the seriousness of PAD, these resources are welcome additions to libraries for interventional radiologists and primary care physicians who want to learn more about minimally invasive treatments for this disease that affects an estimated 10 million people in the United States.

10 Sep 2009

Hospital executives weigh benefits, risks of health reform

Hospital executives are balancing their hopes that expanded coverage will provide a windfall for facilities now burdened by uncompensated care with their fears that government intervention, such as the possible creation of a public insurance option, could cut into their revenues, the Atlanta Journal-Constitution reports.

10 Sep 2009

Clinical study investigates laboratory and clinical implications of proton pump inhibitor drugs

Fears about the cancer causing effects of the second most prescribed group of drugs in the Western world have been put to rest, following the largest ever study into their use.

10 Sep 2009

Obesity experts call on policymakers to adopt obesity recommendations

The Obesity Society and other steering committee members of the Strategies to Overcome and Prevent (STOP) Obesity Alliance, and two former US Surgeons General, join together today to develop effective recommendations to urge policymakers to act on the inclusion of obesity as the largest and most urgent driving factor in healthcare reform.

10 Sep 2009

Miracles of the immune system discussed at the 2nd European Congress of Immunology

"I think it will not surprise you if I say that the immune system is one of our most important organ systems. Its relevance is obvious if only for the fact that it has been reinvented several times throughout the evolution of life," says Professor Andreas Radbruch, President of the German Society of Immunology and Director of the Deutsches Rheuma-Forschungszentrum, Berlin. He lectured about the miracle of our immune system at the Opening Press Conference of the 2nd European Congress of Immunology.

10 Sep 2009

Cancer News and Research

Latest Cancer News and Research

Cancer Research UK launches a new Cancer Centre at Cardiff

Complete Genomics sequences and delivers 14 human genomes

SRA to provide scientific peer review services to Cancer Prevention and Research Institute of Texas

Business operations to be hit in the event of H1N1 outbreak

Lack of awareness in aged men reagarding prostate cancer treatment options

Nanobio hybrids for brain cancer therapy

Therapeutic principles of monoclonal antibodies

New type of stem cell in the prostate may be a source for prostate cancer, say researchers

New Influenza A/H1N1 detection kit launched

Vespa USA supports breast cancer awareness programs

Roche Group and ImmunoCellular Therapeutics sign research agreement regarding ICT-69 antibody

Lead exposure may result in cardiovascular mortality

Oral and throat cancers linked to human papilloma virus

GlaxoSmithKline's CERVARIX receives favorable recommendation from FDA Advisory Committee

Nasdaq Stock Market issues delisting notice to Metabasis Therapeutics

Society of Interventional Radiology's resources emphasize on PAD

Hospital executives weigh benefits, risks of health reform

Clinical study investigates laboratory and clinical implications of proton pump inhibitor drugs

Obesity experts call on policymakers to adopt obesity recommendations

Miracles of the immune system discussed at the 2nd European Congress of Immunology

Understanding the DNA Damage Response in Innate Immunity eBook

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Cancer News and Research

Latest Cancer News and Research

Understanding the DNA Damage Response in Innate Immunity eBook

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Newsletters you may be interested in